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Nonparametric Regression Analysis of
Data from the Ames Mutagenicity Assay
by John B. Cologne'and Norman E. Breslow2
TheAmesassay hasreceivedwidespread attention fromstatisticiansbecauseofitspopularityandimportancetorisk
assessment. However, investigatorshaveyettoroutinelyapplymodemregressionmethodsthat havebeenavailable for
morethanadecade. Westudyyetanotherapproach, theapplicationofnonparametric regressiontechniques, notasthe
ultimatesolutionbutratherasaframeworkwithinwhichtoaddresssomeoftheshortcomingsofothermethods. Butnon-
parametric regressionisitselfpronetodifficultieswhenappliedtoAmesassaydata, asweshowthroughtheuseoftwo
examples and somesimulationstudies. Weargue thatthere remains agreatneed forfurther developmentofstatistical
methods suitable to the Amesassay. It is hoped that such work can be stimulated and guided by greatercollaboration
between statisticians and laboratory investigators.
Introduction
The Ames (Salmonella/histidine reversion) mutagenicity
assay (1,2) maybethe mostpopularshort-termprocedure forthe
evaluation of chemical mutagenic and carcinogenic potency.
Because of its central role in risk assessment, the assay has
receivedtheattentionofnumerous statisticians whohavesought
to develop and apply appropriate methods ofanalysis with the
goal ofproviding valid tests ofmutagenicity and estimates of
potency. Breslow and Kaldor (3) reviewed the wide range of
statistical methods that have been proposed for use with the
Ames assayandothermutagenicity assays. Inparticular, modem
methodsinvolvingregressionmodelsandincorporating assump-
tionsconcerningbiological mechanisms anddistributional prop-
ertiesofthe responsedatahavebecomeavailableandshouldbe
preferred overthe use ofsimpler, more classical methods.
In light ofthese advances, it might be expected that investi-
gatorswouldroutinely apply modemmethodsofanalysis. Yet,
an informal scan of recent volumes of one majorjournal revealed
thatthesemethods arealmost neverusedbyinvestigators. Most
inferencesregardingmutagenicity seemtobebased onclassical
methodsofanalysis (e.g., simpleregression orANOVA, multi-
ple m-tests, etc.) or evennonstochasticmethods such asthetwo-
foldrule(4). Theproblemofbridgingthe gapbetween statisti-
cians andtoxicologists therefore remains tobe overcome. This
contrasts sharply withthefieldsofepidemiologic researchand
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clinical trials, where modem regression methods are much in
vogue.
Given this state ofaffairs, is it reasonable to introduce new
methodsandtofurtherdevelopexistingones? Shouldnotefforts
be directed toward facilitating better application of existing
methods?Wewouldarguethatbothproblemsrequirefurtherat-
tention, namely: a)Statisticianshavenotyetachievedanultimate
solutiontotheproblemofhowbesttoanalyzeAmesassaydata;
andb)investigators shouldmakeconcertedeffortstounderstand
and apply, with the aid of statistical collaborators, modem
methodsofanalysis. Inthis way, investigators canhelp statisti-
cianstoevaluatetheutility ofvariousmethodsbyproviding in-
putastotheirperformanceonalargeamountofrealdata. Such
feedbackshouldenablestatisticianstodevelopbettermethods.
Weshouldinterjectatthispointthatwestronglyadvocatecol-
laborationbetweenstatisticiansandlaboratoryinvestigators. We
do notdeem simplicity or ease ofunderstanding on thepartof
nonstatisticians to be the only criterion for recommending
methodsofanalyzinglaboratory data. Proposingoverly simple
and statistically inefficient methods to make thempalatable to
statisticallyuntrainedresearcherscanleadtomisleading results
and, perhaps, distrust ofstatisticians. We hope that this con-
ference, bybringingtogether statisticiansandtoxicologists, will
allowtoxicologiststoacquirebetterunderstandingofstatistical
methodsandhelpbuildthekindofcollaborationthatwillfurther
the interestsofboth fields ofendeavor.
Withtheseintroductory ideas inmind, we turnnow to focus
specificallyonthefirstissue, theneedforfurtherdevelopment
ofmethods ofanalysis. Wewill notaddress the issue offacili-
tating better application. We propose a new direction for
methodological development in the area ofthe Ames assay -
nonparametric regression - and present a specific example
basedonthesmoothing spline. Thispaperisnotmeanttobethe
finalwordonstatisticalmethodsfortheanalysisofAmesdata,
nor do we wish to imply that the present method is the onlyCOLOGNEANDBRESLOW
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FIGURE 1. Illustration ofthe Ames assay. Mutantbacteria (S. typhimurium; ovals) areapplied toplatescontaininggrowthmedium(including histidine) and the test
chemical. Thechemical maycausemutation(M)orcelldeath, oritmayhavenoeffect. Afterhistidine isdepleted, only histidine-independent reverse mutants
cancontinuetodivide, producingcoloniesthatarevisibleasspotsontheplate(right). Themicroorganismsthatsurvivebutdonotreverse-mutateformadiscoloration
oftheplatecalledthe "background lawn." Withseveretoxicity, mostmicroorganisms arekilled, sothatthebackground lawnisabsent; suchplatesaretypically
excluded from analysis.
possible application ofnonparametric regression methods. In
fact, itwill beseenthatthisnewmethodmayatpresenthaveonly
limitedusefulness. Rather, weuseourapproachasaframework
within whichtoevaluatestate-of-the-art methodsandcharacter-
izethe needfor furtherresearch. Intheend, wehopeitwillbe
obviousthatthereremainsagreatdealofworktobedonetoover-
come problems that exist in currently available methods. This
workcouldbeintheformofbetteralternativemethods, further
developmentofexistingmethods, orcomparativestudiestopro-
videguidanceastowhenandhowexistingmethodsshouldbeap-
plied. Itisexpectedthatallofthese canandshouldbeperformed
in close collaboration with laboratory investigators.
Overview ofthe AmesAssay
Figure 1 summarizes the Ames assay. Mutant strains ofthe
bacterium Salmonella typhimurium, which are dependent on
histidine forgrowth, areplated onpetridishesthatcontain the
test chemical and a limited amount ofhistidine in the growth
medium. The end point is reverse mutation to histidine in-
dependence, which isdetectedbytheexistenceofsurvivingcol-
oniesofbacteriaafterhistidinehasbeendepleted. Theoutcome
ofinterest for statistical analysis is the frequency ofsuch col-
onies. Severaldosesoftestchemical areused, includingazero-
dose control. Each dose is typically tested in duplicate or
triplicate. Interesting statistical featuresofdataarising fromthe
Amesassayincludeoverdispersion(relativetoPNissonsampling)
and competing underlying dose responses (mutagenicity and
toxicity).
It is often desirable to condense the results ofan assay to a
single number, the "mutagenic potency," to rankandcompare
differentchemicals. Themostcommonpotencymeasureusedin
the Ames assay is the initial slope of the mutagenicity dose
response. Thetwomajorgoalsofanalysisaretotestformutagen-
icity andtoestimatemutagenic potency (givenapositivetest).
Often, the mutagenicity test isbasedonthepotency estimator,
buttherearemethodsthattestmutagenicity independently from
potency estimation [e.g., Simpson and Margolin (5)1.
Throughoutthispaper, weusetheinitial slopebothtoestimate
potency and to test for mutagenicity. We leave it to others to
discuss potency measures and their relative advantages (6,7).
Twoexamplesfromtheliteraturedemonstratethewidevariety
of data encountered in the Ames assay. The first (Fig. 2a)
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FiGuRE 2. 'NoexamplesofAmesassay results fromtheliterature. (a) Coal
tar base extract data (8). Fitted curves represent point rejection (- -),
nonlinearregressionusingEquation 1 (- --),andthesmoothing spline(-).
(b)Quinolinedata(9). Fittedcurvesrepresentpointrejection (- --), non-
linearregressionusingEquation 1 withoutthequadratic term(--),quasi-
likelihoodwithaloglinearmodel(- --)(12),andthesmoothingspline(-).
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concerns mutagenicity ofbase extract from crude tar effluent
followingcoalgassification (8). Inthisexample, thepresenceof
amutagenic effect seemsclear, and wecanascertainthenature
ofthedose response fromaplotofthedata. Note, however, the
possibility oflittle or no mutagenic effectatlowdoses because
ofthequadratic shapeofthelow-doseresponse. Fittedlinesare
the estimateddose responses from nonlinear regression, point
rejection, and nonparametric regression (see subsequent
sections).
The second example (Fig. 2b) is from a study of the
mutagenicity ofthechemical quinoline (9). Inthisexampleitis
noteasy toascertain thedoseresponsebecauseofthevariabili-
ty inthedata, althoughbothmutagenicity andadownturndueto
toxicity athighdosesareevident. Fittedcurvesarefromthepoint
rejection, nonlinear regression, quasi-likelihood, and non-
parametric regression methods (see subsequent sections).
We will keep mathematics toaminimum, focusing ratheron
concepts. Nevertheless, somebasic notation is required. Let Yij
be the observed frequency atdose i (i = 1, . . ., K), replicate]
(1 = 1, . .. ,ni) andlettheactualvalueoftheithdosebexx(xi =
0). Let the mean and variance ofYijbe Hi and ai?, respectively.
Thetotal sample sizeis n= K ni. Finally, callthemutageni-
city and survival functionsM(x) andS(x), respectively, andlet
thecompositedoseresponsefunctionbe14(x), theexpectedmu-
tant frequency given dosex.
Regression Analysisof
Ames Assay Data
Breslow andKaldor (3) have reviewed statistical methodsfor
analyzing Ames assay data. We mention here only modern
methods that specifically accommodate regression analysis of
Poisson data. All such methods are based in some way on the
model ofbacterial mutagenesis ofHaynes and Eckardt (10),
g(x) = N0M(x)S(x)
where M(x) and S(x) areexponentiated polynomials andNo is
the(unknown) numberofplatedorganisms. Atypicalexampleis
R(x) = (MO + m x + m2X2)eSX (1)
whereM(x) isapproximatedbyitsexponent, whichispresumed
tobesmall. [NotethatNohasbeenabsorbed intotheparameters
of M(x); we subsequently write MN(x) in place ofNoM(x).]
Suchmodelshavebeenfitbynonlinearregression(8), Poisson
maximum likelihood (11), quasi-likelihood (12), and adaptive
procedures [e.g., the point rejection method (13) based onthe
negative binomial likelihood]. Theparameters mo(spontaneous
mutant frequency) and ml (mutagenic potency) in Equation 1
may beconstrained tobenonnegativeifdesired, butthis is not
necessary inpractice. Backgroundmutationfrequencyistypical-
ly largeenoughthat moisnotestimatedcloseto , andnegative
estimates of m, can be taken as no evidence of low-dose
mutagenicity.
Margolin andothers (9,14) havegeneralizedthesemodels to
incorporatemultiplegeneration effects intheassay, fittingtheir
models with maximum likelihood using thenegativebinomial
distribution. InthispaperweusetheirmultigenerationmodelIV
(9), withthreegenerations formutagenesisandhistidinedeple-
tion and unlimited toxicity, to generate random data for
evaluatingtheperformanceofvariousmethods. Theformofthis
model is
[2S(x)-1]
2
(2[l-M(x)]S(x))i 9~3,0(X) = NOM(X) +E(2 SWx i=0 (2)
where [a]+ = max(0,a).
Severalrestrictiveassumptions accompanytheuseofHaynes-
Eckardt models. One is that mutagenicity and toxicity are
stochastically independent. Ifsuchindependencedoes nothold
(e.g., mutantshavedifferentsurvival rates), thenamoregeneral
model may be needed. Another is the lack of metabolic and
mutagenic mechanisms in the model. Indeed, one major
criticismoftheAmesassayasusedforhumancancerriskassess-
ment is that it lacks the complex chemical and cellular
mechanisms involved inhumancarcinogenesis [briefly reviewed
by Weinstein (15)].
Apartfromtheissueofvalidityofthebasicmodelitself, other
difficultiesariseinthecaseofspecificmethods. Forexample, the
point rejection method circumvents toxic effects by rejecting
high-dosepointswhenthereisasignificantdownwarddeparture
from linearity. Two potential sources of bias are: a) model
misspecification whenthedoseresponseisnonlinearandb)one-
sided (downward only) point rejection, which can occur by
chanceeveninthe absenceoftoxicity. Themultiplegeneration
modelistheoretically quiteattractive, butthechoiceofgenera-
tiontimes canhave a substantial effectonthe magnitude ofthe
estimated potency (9).
Although all methods have potential deficiencies in the
response model, allthemethodsmentionedaboveaccommodate
nonconstantPoisson variance andoverdispersion (withthe ex-
ceptionofmaximumPoissonlikelihood). Inpractice, they seem
toperformwellinmanyexamples, but morewidespreaduseof
thesemethodswouldfacilitateamuch-neededcriticalevaluation
oftheir general applicability. In a later section, we use Monte
Carlo studies to characterize, for some ofthese methods, cir-
cumstances in which they are mostappropriate.
Nonparametric Regression
Inthissectionweonlybrieflydescribeoneapproachtoanalyz-
ing Ames data by nonparametric regression. Technical details
will be made available elsewhere (Cologne, in preparation); a
briefoutline is presented in the Appendix.
Motivation
Before introducing our approach mathematically, it may be
useful to motivate it from a nontechnical perspective. The
hypothetical data shown inFigure 3 provide anexaggerated il-
lustration ofthe concept offitting nonparametric functions to
data. Mostinvestigatorswillbefamiliarwiththeuseofthesam-
plemeansplusorminustwostandarderrorsasdepictedinFigure
3a. A straight lineconnecting themeansgives someindication
ofthe dose response, butitis acrudeand inefficientestimate.
Furthermore, theinitial slopeestimateisbasedonlyonthefirst
twodoselevels, ignoringinformationabouttheshapeofthedose
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FIGURE3. Hypothetical Ames assay data used to illustrate the concept ofnonparametric regression. (a) Simplestraight lines connecting sample means. (b) Haynes-
Eckardtdose-response models with linear( * ) andlinear-quadratic (- - -) mutagenicity (Equation 1). (c) Acubic interpolating spline. (d) Acubic smoothing
spline. Panels aand cillustrateinterpolating curves, whichfrequently overfitthedata, producinghighly variablepotencyestimates. Panelsbanddrepresentvarious
degrees ofsmoothing by a mathematical model; the cubic smoothing spline model is less restrictive than the Haynes-Eckardt dose-response model.
response. Finally, the model interpolates the sample means,
thereby ignoring their variability.
Parametric models attempt to account for variability in the
sample means by smoothing them according to some
mathematical model (suchasEquation 1 oftheprevioussection).
Figure 3b shows linear and linear-quadratic Haynes-Eckardt
models fit to these data. Initial slope estimates based on these
models incorporate information from the entire experimental
range ofdoses, notjust the first two doses. However, neither
model fitsthedatawell; presumablytheydo notreflectthetrue
mechanistic model. Inaddition, differentmodelswithseemingly
equivalentfitstothedata canproducedisparatepotencyestimates
(as iswell knownto occurinthe caseoflow-doseextrapolation
in the animal bioassay).
As analternative, weconsiderusing ageneral class ofmathe-
matical functions, ratherthanthespecific functionsimpliedby
use ofthe Haynes-Eckardt model. Figure 3c shows the fitofa
"cubic interpolating spline," a piecewise polynomial function
that connects points in a smooth fashion. (In fact, the line in
Figure 3a is a linear interpolating spline.) The amount of
smoothness at the dose values depends on the degrees of the
polynomials (compare Figure 3c to Figure 3a). We can add
higher-order polynomial terms to make the function more
smooth at the dose values. Generally, cubic splines are suffi-
ciently smooth sothathigher-orderterms arenotnecessary, but
byinterpolating the means, thecubicinterpolating splineagain
ignores sampling variability. The result is often a curve that is
extremely wavy in the regions between dose values.
The final step is to "penalize" thespline in such a way thatit
neitheroverfits (interpolation, leadingtolargevariability inthe
estimated response) noroversmooths(straight lineregression,
leading tobiasintheestimatedresponse). Thisisdoneby cross-
validation, amethodthatbalancesbiasandvariabilitybyletting
thedatadeterminetheoptimal amountofsmoothness. Figure 3d
showsthefitofsuch a "cross-validatedcubicsmoothingspline"
to these hypothetical data. The fitted curve more closely des-
cribestheunderlying responsethanthoseinFigure3b, because
it is based on fewer assumptions concerning the mathematical
formofthe response.
The useofflexible, nonspecific, smooth functions to fitdata
isgenerallycalled "nonparametricregression." Note, however,
that there is no clear separation between parametric and non-
parametricregressionmethods. Thedifferenceisthedegree to
whichthefitted curveisconstrainedby amathematical model.
Parametric regression is based on specific models thought to
describe, oratleastapproximate, underlyingbiological mecha-
nisms, whereasnonparametric models encompass awiderclass
ofmathematical functionsthathave no suchbiologically based
interpretation. Furthermore, nonparametric regressionproduces
parameters; ingeneral, thenumberofparameters with nonpara-
metric regression willbelargerthan with aparametric model,
reflecting the greater flexibility ofthenonparametric function
(i.e., ouruncertainty aboutthe truemodel).
Ingeneral, there is atrade-offinvolved inchoosing between
parametricandnonparametric regressionmethods. Ifthemodel
iscorrect, weexpectthattheparametricmodelwillprovide more
powerful inference concerning mutagenicity and potency.
However, if the model is wrong, the results can be biased,
possiblyleading us toincorrectconclusions. Theredoes notyet
seem to be any single mathematical model for the Ames assay
thata)incorporatesallofthebiological featuresoftheassay,b)
requires nounverifiableassumptions, andc) canbesuccessfully
a
0-
c
60~
=l) 2.
b j
i N11~~~ . .
......................1
.
.. , %A . i
wcf
c at 1
-
i \\
. / \ , \\
v Il
Ia
I
0 5 10 15
d ,- X
.1 .,'} 'I
64NONPARAMETRICREGRESSIONANALYSISOFAMESASSAYDATA
fit to thevariety ofresults encountered inpractice. The lackof
suchamodelmotivatedustoinvestigatethepossibleapplicability
ofnonparametric regression methods to Ames assay data.
Implementation
We have chosen to use the cubic smoothing spline (CSS)
becauseitisvisuallysmoothandiseasilydifferentiated. Thelat-
terisimportantforcomputingpotency, whichrequirescalcula-
tionoftheinitial slopeofthedose-responsecurve(seethenext
sectionforsomediscussionofbiasesinCSSestimationofpoten-
cy). DetailedtreatmentoftheCSS isavailableelsewhere(16,17).
The CSS is the solution k(x) to the following penalized
weighted least-squares problem: minimize
1 [Y. - g(x+)] x [g"(x)]2dx (3
n i=1 j=1 x
overthesetoftwicecontinuouslydifferentiablefunctionsgwith
squareintegrable secondderivative. Thesmoothingparameter
X 2 0determineswherethesolutionliesbetweenastraightline
(as X - oo) and a cubic interpolating spline (as X - 0). The
estimator is a setofpiecewise cubic polynomials
g(x) = gi + 1i(x - xi) + -i(X Xi)2 + Si(x - xi)3 (4)
(xi < x < xi+,, i = 1, . . ., K-1), which are constrained to be
continuous andtohavecontinuousfirstandsecondderivatives.
These constraints result in a reduction of Equation 4 to K
parameters, which we maytake tobethefittedvalues jii=g(xi).
For fixed X, Equation 3 reduces to a setoflinearequations
= (gL
. **,I 9)T =B(X)y
where y = (y,..., yK) isthe vector ofsample means and
B(X) is a smoothing matrix depending on the ui and the xi but
not ony (see the Appendix).
An obvious estimator ofmutagenic potency is (3k, the initial
slopeofthepiecewise curve(Eq. 4) fit tothe segmentbetween
xI = 0andx2, thelowest nonzerodose. Notethatis, depends on
theotherdatapoints aswell; infact, This alinearcombinationof
it:
= aTp = aTB(X)y
with a being a known vector (Appendix), and so i31 is also a
linearfunctionofy forfixed X. Thevarianceof(31 iseasilyob-
tainedusingdistribution theoryforlinearcombinations ofsam-
ple means.
In practice, X and the at must be estimated. Because of
replicates intheAmes assay, wehave theusualunbiasedsample
variance estimates
2 1
whichordinarily arenotavailableinCSSapplications. Thevalue
of X is chosen optimally according to cross-validation by
minimizing
(Y. - 2
CV(X)= -
ni~~~n
with respect to X, where biis the ith diagonal element ofB(X)
and the ji depend implicitly on X. We denote cross-validated
estimators by an asterisk(*).
Althoughthecross-validated fittedvaluesji* arenotalinear
functionof -, itmaybeshownthat, forafixedsetofdosevalues,
asymptotically, j*andy havethesamedistribution ifthenum-
ber ofreplicate observations increases at each dose (18). This
result is especially useful in providing a means ofmaking in-
ference concerning the inital slope. Since i,' isalinear function
of j*, itis asymptotically a linearcombination ofy and so has
alimiting normal distribution:
- N(O, aTla)
wherefB isthe initial slopeofacubicinterpolating spline fitto
21
thevectoroftrue means I = (ju, .. ., r F = diag 'vyf
andO < vi = lim-< < isthe limiting fractionofpointsat
xi. Wemaythereforebaseinferenceconcerningtheinitial slope
uponthe standard normalz score
z= A;
SE(f3)
assuming 3,B is close to the true mutagenic potency (see the
discussionofbiases inthenextsection). MonteCarlostudiesof
the small samplebehaviorof(t (notshown) revealthatboth its
bias and variance can be strongly affectedby estimation ofthe
smoothing parameter X. The magnitude of these effects is
evaluatedbriefly incomparison studiesdiscussedbelow.
Biases in the Potency Estimator
The validity of (3r as a potency estimator depends on the
unknown model A (x) because (3i estimates '(0) rather than
M'N(O) [recallMn(x) = NoM(x)]. Intheabsenceoftoxicity orin
the case ofatoxicity threshold, ji'(0) = M'N(O). But without
knowledgeofg(x), itisnotpossibletoobtainMN(x). However,
if the data are generated by Haynes-Eckardt-type models or
multiple generation models, it is possible to directly estimate
M'N(0) and also to calculate A'(0), so that we may assess the
impactofignoringthesurvivalfunctionS(x). Letthedifference
bias, = ,s'(0)-M'N(O) be called the "toxicity bias." Some
algebra shows that, in the case of Equation 1, bias, = -mos
(3), whereas for the multigeneration Equation 2, bias, =
-NoZ where
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The validityof 3,r alsodepends onhowwell acubic spline ap-
proximates the true dose-response function g(x). Let biasa =
, - u'(0) be called the "approximation bias"; this is the bias
due to approximating the initial slope ofA(x), using the inter-
polating splinefittothetrue means. Thisbias maybecalculated
for specific dose-response modelsby simulating themodeland
fittingthecubic interpolating spline. Figure4showstherelative
biasbias, /1 '(0) as a function oftrue mutagenic potency ml in
Haynes-Eckardt (Eq. 1)andmultigeneration (Eq. 2)models, us-
ing various values of the toxicity parameter s (0.001, upper
panels; 0.01, lower panels). In these simulations, six dose groups
wereusedwith relative spacing (0,0.015625,0.125,0.25,0.5, 1);
the highest dose was calculated to give either 90% or 10% sur-
vival. [The appropriate maximum dose for achieving 90% or
10% survival with the multiple generation model assuming
unlimitedtoxicity may becalculated usingprobabilitiesderived
by Margolinetal. (9).] Theseresultsshowthatthespline approx-
imation bias is quite large with 10% survival, presumably
because there are insufficient data for the spline to mimic the
dose-response structurebetweenthefirsttwodosevaluesinthe
low-doseportionofthe curve. Increasingthequadratic termalso
increases the relative bias.
Finally, there will bebias due to estimation ofthe smoothing
parameter X; callbias, = St - (3 the "smoothing bias." Accor-
ding totheaboveasymptotic distributionthesmoothingbiaswill
be small in large samples. This bias is not easily computed
theoretically, butit maybeascertainedfromMonteCarlostudies
by subtracting the toxicity and approximation biases from the
total bias oftheestimator, as illustrated inthe nextsection. The
total bias inOf1 as an estimate ofmlin Equation 1 is
biast = -
11= - 1i] + [31 - g'(0)] + [p!(0) - ml]
= biass + biasa + biast
so bias,
= bias. bias, biasa. Note that bias, and biasa are
functions ofthe unknownjt(x), so they cannotbe individually
ascertained except by knowledge ofl(x). On the other hand,
bias,is a small samplebiasthat canbemadesmall by the useof
sufficiently large samples.
Comparative Studies
We nowdescribeMonteCarlostudiesdesignedtoevaluatethe
CSS approach and compare the CSS to two other regression
methods: nonlinearregressionandthepointrejectionmethod.
Wealso comparethefitsofthesemethodstothetwoexampledata
sets introduced earlier. The multigeneration approach of
Margolinetal. (9,14) wasnotcomparedbecauseofthedifficulty
ofestimating the generation times.
Monte Carlo Studies
In the Monte Carlo studies we used a variety of Haynes-
Eckardt and multigeneration models, with varying degrees of
curvature andeither90% or 10% minimum survival, to obtain
random Ames assay type data. All studies were based on five
doselevelswithrelativespacing (0, 0.125, 0.25, 0.5, 1). Random
Poisson ornegativebinomialvariables weregeneratedaccording
toalgorithm "NG" ofAhrensandDieter(19). Threereplicates
weregenerated ateachdose. Each experimentconsistedof2000
simulateddata sets. Ifthere was noquadraticmutagenicity term
(m2 = 0) in the model that generated the data, we fit a linear
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FIGURE 4. Interpolating spline relative bias inthe initial slopeestimator. Results are fordose responses simulated according toeither Equation 1 or Equation2,
using various values ofthequadratic mutagenicity term: [m2 = 0 (-), M2 = 0.01 (- - -), and M2 = 0.1 (- - -)J, survival parameter (s = 0.001, upperpanels; s
= 0.01, lower panels).
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Table 1. Simulated comparisonsamongthesoothingspline, pointrejection, and nonlr sessionmethods: Haynes-Eckardt modelswith90% survival.
ml=0, m2=0.01, s=0 ml=2, m2=0, s=0.01 m1=2, m2=0.1, s=0.01
Distribution Distribution Distribution
Method Parameter P NB P NB P NB
Ss Potency 0.18 0.18 1.65 1.59 2.12 2.07
SSE 0.23 0.31 2.17 2.37 2.33 2.14
CSE 0.43 0.45 2.62 4.05 3.86 4.10
Power 0.059 0.067 0.45 0.17 0.16 0.16
PR Potency 0.93 0.93 1.80 1.82 2.55 2.57
SSE 0.05 0.07 0.77 0.84 0.57 0.59
CSE 0.10 0.10 0.50 0.52 0.48 0.50
Power 1.0 1.0 0.94 0.90 1.0 0.99
No. of 5.0 5.0 4.8 4.8 4.9 4.9
points
NR Potency -0.11 -0.13 3.52 3.65 1.56 1.39
SSE 0.21 0.23 1.85 2.0 2.18 2.49
CSE 0.24 0.27 2.96 3.17 3.22 3.58
Power 0.011 0.010 0.37 0.33 0.12 0.096
No. of 1570 1632 1916 1933 1610 1545
convergencesb
Abbreviations: SS, smoothing apline; PR, pointrejection; NR, nonlinear regression; P. Poisson; NB, negativebinomial; SSE, sampling standard error; CSE,
computed standard error; mI, linear term; M2, quadratic term; s, toxicity term.
aAverage number ofretained points afterpoint rejection.
bNumber ofcases in which NRconverged.
mutagenicity model with nonlinear regression [Eq. 1 with M2
= 0]; otherwise we fit the full model (Eq. 1). With all three
methods, thetestofmutagenicity wasbased onasymptotic nor-
mality oftheinitial slopeestimatordividedby its standard error.
Power wasestimated for aone-sided level0.05 testby the pro-
portion oftimes the z score exceeded the critical value 1.645.
Thefirst setofresults (Table 1)isfordatageneratedbyEqua-
tion 1, taking mo = 25 andusing various values ofmi, m2, and
s at 90% minimum survival. Sampling standard error is the
standarddeviationofpotencyestimates fromthe2000simulated
data sets in one experiment; computed standard error is the
averageofthe2000 individual standard errorscomputed from
each simulated data set in anexperiment. Simulateddata were
either Poisson or negative binomial with variance 141 +
0.005A]. Becausethemodelsevaluated werenearly linear over
the range of doses at which 90% minimum survival was
achieved, the nonlinear regression method failed to converge
about 25% ofthe time except in the case where m2 = 0. Most
notable from these studies were the positive bias and inap-
propriate test size ofthe point rejection method under the null
hypothesis (ml = 0) in the presence ofupward curvature, con-
trasted with the lack of power of the smoothing spline and
nonlinear regression methods under the alternative model
(m, = 2). Negative binomial errors (to mimic overdispersion)
led to areduction in powerand aslightincrease instandard er-
rorwitheachmethod. Results fordatageneratedby themulti-
plegenerationmodel with90% minimum survival were similar
and so are not shown.
The second set ofresults (Table 2) is for data generated by
Haynes-Eckardtandmultiplegenerationmodels, usingvarious
parametervalues, andwith 10% minimumsurvival. Formulti-
plegenerationmodels, parametersofthemutagenicity function
M(x) may be approximately related to parameters of the
Haynes-Eckardt modelMN (x) by dividing the latterby 7 X No
(13). We took No = 108. All simulated models displayed
substantialcurvatureoverthewiderrangeofdosesproducedby
allowingsurvivaltodecreaseto 10%, andthenonlinearregres-
sion method nearly always converged. The power ofall three
methods wasgreaterthanintheabovecasesof90% minimum
survival. Thenonlinearregressionmethodperformedquitewell
on data generated by Haynes-Eckardt models, whereas the
smoothingsplineandpointrejectioninitialslopeestimates were
highly sensitive to the magnitude ofthe quadraticterm.
Withmultiplegenerationmodelsand 10% minimumsurvival,
the smoothing spline wasthe only method able toclosely esti-
mateasmallpositivepotency (lastcolumnofTable2). Thenon-
linearregressionmethodgavehighlybiasedandvariableinitial
slope estimates, whereas the point rejection method over-
estimated the initial slope whenthe truepotency was small.
Asanexampleofthetotalbiascalculationsforthesmoothing
spline(seetheprevioussection), considertheestimate 1.65from
Table 1 (mi, = 2, M2 = 0, s = 0.01, with Poisson errors and
90% survival). The totalbias is
bias=, - = =1.65 - 2 = -.35
Now
bias, = -mOs = -25x.01 = -.25
and, from calculation ofthe interpolating spline fit to the true
means, biasa = -0.01. Thus
biass = -.35 + .25 + .01 = -.09
is the amountofbias in,3* dueto smoothing.
ExampleData Sets
Earlier, we introduced two example data sets from Ames
assaysofcoaltarbasefraction(Fig. 2a)andquinoline(Fig. 2b).
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Table2. Simulated comparisons amongthesmoothingspline, point rejection, andnonlinear regression methods:Haynes-Eckardtmodelswith 10% survival.
Haynes-Eckardt, m, =2, s=0.01 Three-generation, s=0.01
m,=2 ml =0.1
Method Parameter m2=0 m2=0.1 m2=0 m2=0.1 m2=0.01
SS Potency 1.29 3.18 0.91 1.79 0.19
SSE 0.25 0.37 0.54 0.63 0.59
CSE 0.27 0.36 0.76 0.81 0.70
Power 0.99 1.0 0.28 0.73 0.061
PR Potency 1.0 4.08 0.79 1.82 0.87
SSE 0.11 0.10 0.32 0.29 0.15
CSE 0.11 0.11 0.26 0.22 0.16
Power 1.0 1.0 0.63 1.0 0.99
No. ofpoints 3.0 4.0 3.2 3.7 4.0
NR Potency 2.01 1.97 4.35 -0.91 -1.63
SSE 0.19 0.52 0.64 1.57 1.17
CSE 0.18 0.51 0.93 1.97 1.48
Power 1.0 0.97 1.0 0.14 0.001
No. of 2000 2000 2000 1998 2000
convergencesb
Abbreviations: SS, smoothing spline; PR, pointrejection; NR, nonlinear regression; P, Poisson; NB, negativebinomial; SSE, sampling standard error; CSE,
computed standard error; mI, linearterm; M2, quadratic term; s, toxicity term.
aAverage number ofretained points after point rejection.
bNumber ofcases in which NR converged.
Table3. Initial slope inference forexample datasets.
Method Parameter Coal base data (8) Quinolinedata (9)
Smoothing spline Estimate 0.52 0.18
SE 0.13 0.50
z Score 0.46 0.36
Point rejection Estimate 17.0 0.24
SE 0.8 0.06
z Score 21.3 4.0
Nonlinear regression Estimate -1.0a 0.20b
SE 3.5 0.07
z Score -0.29 2.9
aEquation 1 with linear-quadratic mutagenicity.
bEquation 1 with linearmutagenicity.
Table 3 displays estimated potencies obtained from the three
methods compared above, along with standard errors and z
scores.
AswiththeMonteCarlostudies, thereislargebiasinthepoint
rejectionslopeduetoanupwardlycurvingresponseinthecase
ofthecoalbasedata. However, thepointrejectionmethodisthe
mostpowerful inthecaseofthequinolinedata, inwhichthelow-
dose linearity assumption appears reasonable, and all three
methods gave similar estimates. The smoothing spline dose-
response estimate forthequinoline dataappears strange inthe
high-doseregionbecausethereisalargegapwithnoinforma-
tion between the highest and next highest doses (a seemingly
uninteresting regionofthedoseresponse). Thispoints outthe
need to consider issues ofexperimental design; the sametotal
sample size applied to a narrower dose range would provide
more information concerning mutagenic potency.
Conclusions
Each ofthe methods we comparedperformed best in situa-
tions where its assumptions most closely held true. The
nonlinear regression method [based on the Haynes-Eckardt
model (Eq. 1)]performedwellwhenthetruemodelwasEqua-
tion 1 and the dose range was wide enough that all of the
parameters were estimable from the data. The point rejection
methodwasquitepowerful whentheunderlyingdoseresponse
wasnearlylinear, butotherwiseitoverestimated mutagenicef-
fects. The smoothing splineperformedbestinsituations when
thenonlinearregressionwasinappropriatebecauseofthewrong
model (e.g., withmultigenerationmodels) andwhenthepoint
rejectionmethodwaswrongduetocurvatureintheinitialdose
response (e.g., with nonlinear models and wide dose ranges).
No single methodperformed well underall situations.
The smoothing spline approach was designed to provide an
alternative to model-based regression methods when the
underlyingmodelisnonlinearanddoesnotfollowEquation 1.
We observed that, when the dose range is selected so that
minimum survivalisatleast90%, evenmultigeneration models
arenearlylinearovertheentiredoserange, sothatthepointre-
jectionmethodproducesquitereasonableresults. Inthissense,
thesmoothingsplineisratherdisappointingbecauseitappears
COLLABORATION
Apply and
evaluate
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Develop
existing _
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< METHODOLOGIC Conduct comparative RESEARCH studies
Find new methods
FIGURE5. Illustration ofneeds for further research into methodologies for
analyzing Ames assaydata.
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that wemayachievemodel robustnessusingthepointrejection
method so long as adequate dosing experiments areperformed
first. However, agreaterunderstandingoftheAmesassayonthe
part ofstatisticians is neededbefore itcanbe saidwhetherthis
willbetruegenerally inpractice. Forexample, day-to-dayvaria-
tion inAmesassay resultsdecreasestheeffectivenessofdosing
experiments (B. H. Margolin, personal communication); this
may leadtodifficulties inattemptstoroutinelyachieveapprox-
imate linearity.
Basedonthelackofasingleacceptablemethod, itappearsthat
more work is needed to further develop existing methods orto
find new methods that will perform well with Ames assay data
withoutbeing soclosely tiedtomodelassumptions. Inaddition,
furthercomparisons among methods areneeded tounderstand
in which circumstances the various methods are appropriate.
Suchstudies, aswell ascomparisonsonanumberofactualAmes
data sets, shouldbeperformed inconjunction withlaboratory in-
vestigators so that situations that are most relevant in practice
maybeidentified andstudied. Figure5 summarizestheneedfor
furtherresearch into statistical methodssuitable forusewiththe
Ames assay. Itemphasizestheimportantrolethatcollaboration
and application should play inthis work. Statisticians can also
contributebyadvising researchers onhowthey candesignbet-
terexperiments soas toobtainthesortofdataneededforrobust
analyses. Finally, itwouldbeuseful tohavemethodsforcompar-
inggoodnessoffitamongthevarietyofmodelsdiscussedinthis
paper. Itishopedthatmorestatisticianswillbecomeinterested
intheseproblemsandthatgreatercollaborationbetweenstatisti-
cians and laboratory investigators will occur in the future.
Appendix
First, letXbefixed. ThesolutiontoEquation3isapiecewise
cubicpolynomial(16), soEquation3mayberewritten: minimize
with S- = diag{i Theymaybecomputeddirectly orvia
theequivalentalgorithm "SMOOUH"ofdeBoor(16)thatsolves
forthethird-order coefficients -y, in Equation 4.
For estimating X by cross-validation, Silverman (21) has
recommendedgoldensectionsearch. Ateachiteration, we com-
puteCV(X) usinggbased onthecurrentvalueofXinthesearch.
Occasionally, becauseofunequal spacingbetweendosepoints,
thereis atendency to interpolate nearby means. Thisproduces
wavy dose-response curve estimates that are unlikely to be
acceptable to investigators. In such cases, we find that mini-
mizing the weighted cross-validation score
w,.E (Y., - pi)2
CVw(X)
= b
2 b.V
nisi -n
using the interval-length weights (D. Ragozin, personal
communication)
(X2 - X1)
2
Xi+1 Xi-i
w. =
Wi- 2
(XK
- XK-1) WK = 2
i=2, . . . , K-l
1 - Jta)TS-1(Y - Jfi) + XqaT n
whereJis theexpansion matrix
in ° ...
J 0 l -
% *- 01
nk
(20), Y =(YlI,. .) .., YI'n ; Y2,,** Y2n2; * ;YKJ' * KA * T ,
isthevectorofallobservations, 0isthe"penaltymatrix," which
dependsonly onthexi, andS = diag[Var(Yij)I (i.e., adiagonal
matrixofthesi suitably expanded). Differentiating and setting
the resultequal to zero, weobtain
J S = (,TS-i + nXQ)-lJTS-ly
= (Sy+ nx4 S;'y
= (X)y
oftenproduces satisfactorily smoothdose-response estimates.
To computethe initial slopeestimator, we usethe factthat Q
may bewritten as0 = QR-1QT, whereQandR aretridiagonal
matrixes (16). Then, usinglinearrelationships amongthecoef-
ficients ofthepiecewisepolynomial (Eq. 4) (16,22),
01 42 - alI X2 Wq= T4
X2 6
where (A is the firstcolumnofQR-1 and
X2
1
x2
0
0
O
0
X2
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